clinical trials

In PD-1 rivalry, Merck's Keytruda catches up with Opdivo in rare lung cancer type
Fierce Pharma
Fri, 03/10/23 - 11:20 am
Merck
Keytruda
Opdivo
Bristol Myers Squibb
pleural mseothelioma
mesothelioma
clinical trials
Astellas Xospata comes up short again in bid to expand leukemia use
Fierce Pharma
Thu, 03/9/23 - 09:13 pm
Astellas
Xospata
AML
clinical trials
Lilly’s Alzheimer’s struggles continue as preclinical asset fails phase III
BioSpace
Thu, 03/9/23 - 11:46 am
Eli Lilly
Alzheimer's disease
solanezumab
clinical trials
Tagrisso reaches OS endpoint in PhIII EGFR-mutated lung cancer trial
Endpoints
Thu, 03/9/23 - 10:00 am
AstraZeneca
lung cancer
clinical trials
Tagrisso
eConsent in clinical trials: what’s new and what’s yet to come?
Clinical Trials Arena
Wed, 03/8/23 - 09:38 am
eConsent
informed consent
clinical trials
ACC 2023 – the market tries to take Medtronic’s pulse
EP Vantage
Wed, 03/8/23 - 09:33 am
ACC
Medtronic
pulsed field ablation
PulseSelect
clinical trials
devices
Medtech
Amarin Posts New Data Showing Benefit of Vascepa In High-Risk Patients With Acute Coronary Syndrome
Yahoo/Benzinga
Tue, 03/7/23 - 10:16 am
Amarin
Vascepa
Vazkepa
acute coronary syndrome
clinical trials
AstraZeneca, Daiichi Sankyo tease new Enhertu data — but details remain under wraps
Endpoints
Mon, 03/6/23 - 11:27 pm
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
Merck’s oral cholesterol-lowering drug shows similar efficacy to injectable predecessors as it moves to PhIII: #ACC23
Endpoints
Mon, 03/6/23 - 11:15 pm
Merck
PAH
clinical trials
MK-0616
Praxis Shares Fall 48% Following Mixed Data for Essential Tremor Candidate
BioSpace
Mon, 03/6/23 - 11:13 am
Praxis Precision Medicines
ulixacaltamide
clinical trials
essential tremor
Incyte Abandons Phase III Trial for Myelofibrosis Treatment
BioSpace
Mon, 03/6/23 - 11:06 am
Incyte
clinical trials
myelofibrosis
Jakafi
Mineralys reports positive data from trial of lorundrostat for hypertension
Clinical Trials Arena
Mon, 03/6/23 - 10:49 am
Mineralys Therapeutics
clinical trials
hypertension
lorundrostat
Sanofi’s clinical trial of hemophilia A therapy in children meets endpoint
Clinical Trials Arena
Sun, 03/5/23 - 03:12 pm
Sanofi
clinical trials
hemophilia A
Altuviiio
Roche, Exelixis Suffer Another Late-Stage Cancer Combo Failure
BioSpace
Fri, 03/3/23 - 12:01 pm
Roche
Exelixis
renal cell carcinoma
Tecentriq
Cabometyx
clinical trials
FDA rejects Covid-19 drug over uncertainties around small trial
Endpoints
Fri, 03/3/23 - 10:07 am
Veru
clinical trials
COVID-19
ARDS
sabizabulin
Praxis share price halved after essential tremor fail, but biotech still plans phase 3
Fierce Biotech
Fri, 03/3/23 - 10:04 am
Praxis Precision Medicines
clinical trials
essential tremors
ulixacaltamide
Spotlight – What is next in Nash
EP Vantage
Fri, 03/3/23 - 10:02 am
NASH
clinical trials
89Bio
Arrowhead Pharmaceuticals
Can-Fite BioPharma
Ewopharma
Hepagene Therapeutics
JNJ
Ligand Pharmaceuticals
Madrigal Pharmaceuticals
Merck
NGM Biopharmaceuticals
NorthSea Therapeutics
Novartis
Sagimet Biosciences
Terns Pharmaceuticals
Viking Therapeutics
Bristol Myers, J&J plan tests of new blood thinner in nearly 50,000 patients
BioPharma Dive
Thu, 03/2/23 - 10:41 pm
Bristol Myers Squibb
JNJ
clinical trials
Librexia
bloodthinners
Atom Bioscience reports positive Phase IIa chronic gout therapy trial data
Clinical Trials Arena
Thu, 03/2/23 - 09:56 am
Atom Bioscience
gout
clinical trials
ABP-671
Atea dumps dengue drug as 'unevaluable' endpoint causes timelines, forecast costs to spiral
Fierce Biotech
Wed, 03/1/23 - 06:52 pm
Atea Pharmaceuticals
dengue
clinical trials
AT-752

Pages